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Conclusion: Our study suggests that thrombolytic therapy is a
reasonable option for reperfusion therapy even in case of ST
elevation MI presenting after window period, with a lower rate of
periprocedural complication, as compared to PCI.
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Background: The co-administration aspirin-clopidogrel results in
enhancement of platelet inhibition and would improve outcomes
after CABG in terms of graft patency and major adverse cardio-
vascular events.
Objectives: The objective of this study was to examine the clinical
efficacy of clopidogrel treatment on saphenous vein graft patency,
incidence of major adverse cardiovascular events and safety
following CABG at the end of 3 months.
MethodsandResults: In this study, 74patientsundergoing coronary
arterybypassgraftingwithSVGswere randomized toreceiveaspirin
150 mg plus clopidogrel 75 mg daily or aspirin 150 mg plus placebo
daily for 3months. The primary outcomewas saphenous vein graft
patency as determined coronary angiography at 3 months. Sec-
ondary outcomes were major adverse cardiovascular events, and
major bleeding. At the end of 3 months coronary angiography was
performed in 66 patients (89.1%). Overall 3month SVG graft patency
was 95.2% in the aspirin-clopidogrel group compared with 82.1% in
the aspirin-placebo group (P¼0.007), and LIMApatencywas 97.1% in
the aspirin-clopidogrel group versus 96.9% in the aspirin-placebo
group (P¼1.000). Freedomfrommajor adverse cardiovascular events
at 3 months was similar for the 2 groups. The incidence of major
bleeding at 3 months was similar for the 2 groups (8.8 versus 6.25%,
aspirin-clopidogrel versus aspirin-placebo, P¼1.000).
Conclusions: Compared with aspirin monotherapy, the combi-
nation of aspirin plus clopidogrel did significantly improve SVG
patency 3 months after coronary artery bypass grafting without
increasing the risk of major bleeding complications.
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Background: Ostial and ostioproximal stenting have traditionally
been considered complex interventions and higher rate of reste-
nosis was seen in the BMS era. After the advent of DES, though
restenostic rates have come to single figures, most authoritative
guidelines recommend surgical recourse for ostial lesions due to
higher rates of reinterventions and TLR. This retrospective anal-
ysis was conducted at a tertiary care referral centre in South India
to determine intermediate term clinical outcomes and rates of
clinical restenosis at 9th-month follow up.
Methods: Patients who serially underwent coronary intervention
for ostial and/or ostioproximal lesions between Jan 1, 2011 and
Dec 31, 2012 at SSSIHMS Bangalore were studied for their symp-
toms, functional status, comorbidities and echocardiographic
parameters, including LVEF. The demographic parameters
including the age, gender and risk factors, the clinical presenta-
tion and profile, as also the angioplasty details including the stent
deployment data were collected at baseline. At 9th month follow-
up a clinical assessment and echocardiographic follow-up was
conducted.
Results: 72 patients (males¼44, females¼28) underwent PCI in the
above period, of whom 9th month clinical and echocardiographic
follow-up was available in 47 patients (67.4 %). The arteries
intervened upon in ostial location were: LAD in 42, RCA in 23, LCX
in 5, LPDA in 1,and major OM in 1.Two patients had combined
proximal RCA and op LAD stenting. Implanted stents were: DES:
45 and BMS 32 (mainly due to compelling indications). Average
stent size was 3.15 ± 1.35 mm, length-21 mm ± 2.1 mm. In all
LMCA to opLAD stenting proximal flaring of the stent was
performed.
On follow-up at 9 months : in the 47 (36/ 54 ACS : 11/18 SIHD),
patients on follow-up, good compliance with medication was
noted. At least 4 patients had recurrent ACS and underwent a
repeat stenting at our Institute and two definite stent thrombosis
occurred during hospital course.6 patients were referred for CABG
due to ISR and recurrence of symptoms, of whom poor drug and
DAPT compliance was noted in 3 patients. 8 of these 12 patients
had stenting from the initial ACS arm. Excluding these, therefore
35 patients reported as being asymptomatic and return of
acceptable quality of life .Of the 36 ACS ,21 ACS had no change or
fall in LVEF but angina grade improved by at least one grade, in 15
LVEF improved by at least 5 % with improvement in angina,( P
¼0.069 ). The delay in referral from occurrence of ACS to perfor-
mance of PCI could explain the lack of improvement in ACS pa-
tients undergoing ostial PCI.7/11 patients with SIHD had a
preserved LVEF and improvement in angina, 4 patients with SIHD
continued to have symptoms of lower grade of angina and were
managed medically ( P<0.01 for improvement after PCI).
Conclusion: We inferred from our analysis that ostial stenting in
ACS led to improvement in anginal symptoms at intermediate
term follow-up with no significant objective improvement in LVEF
especially in patients with DM; however in SIHD significant
improvement in clinical symptoms with less recurrent events
(less clinical restenosis) supports the feasibility of ostial stenting
in this situation.
Prevalence and association of major coronary risk
factors with CAD: Single centre study
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Background: Different studies in our country on risk factor prev-
alence and association with CAD have shown varying picture. No
major large scale study has been done in this part of the country.
Methods: This is a retrospective cross sectional observational
study. We collected data from inpatient and outpatient records
between 1995 and 2010. Data were collected with respect to
presence of DM, HT, Smoking and levels of TC, HDL, LDL & TG and
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